SARS-CoV-2 is the virus responsible for the ongoing COVID-19 outbreak. The virus uses
ACE2 receptor for viral entry. ACE2 is part of the counter-regulatory renin-angiotensin …

The rapidly evolving pandemic of severe acute respiratory syndrome coronavirus (SARS-
CoV-2) infection worldwide cost many lives. The angiotensin converting enzyme-2 (ACE-2) …

Angiotensin converting enzyme 2 (ACE2) is the recognized host cell receptor responsible for
mediating infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Increased expression of pulmonary ACE2, the SARS-CoV-2 receptor, could contribute to
increased infectivity of COVID-19 in patients with diabetes, but ACE2 expression has not …

The severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) has resulted in almost
28 million cases of COVID-19 (Corona virus disease-2019) and more than 900000 deaths …

Despite the unprecedented effort of the scientific community, the novel SARS-CoV-2 virus
has infected more than 46 million people worldwide, killing over one million two hundred …

Angiotensin-converting enzyme 2 (ACE2), first discovered in 2000, serves as an important
counterregulatory enzyme to the angiotensin II-mediated vasoconstrictive, pro-inflammatory …

This article reviews the correlation between ACE2 and COVID-19 and the resulting acute
respiratory distress syndrome (ARDS). ACE2 is a crucial component of the renin-angiotensin …

Abstract Angiotensin-converting enzyme 2 (ACE2) is the main entry point in airway epithelial
cells for SARS-CoV-2. ACE2 binding to the SARS-CoV-2 protein spike triggers viral fusion …

Angiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract
several pathophysiological actions of ACE. ACE2 exerts antihypertensive and …